Costs of ulcerative colitis from a societal perspective in a regional health care area in Spain: A database study

Gastroenterologia y Hepatologia

Volumn 39, Issue 1, 2016, Pages 9-19

  Aldeguer, Xavier ^a   Sicras Mainar, Antoni ^b  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b Badalona Serveis Assistencials   (Spain)

Author keywords

Indirect costs; Productivity loss; Ulcerative colitis

Indexed keywords

AMINOSALICYLIC ACID; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT;

ABSENTEEISM; ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIARRHEA; FAMILY HISTORY; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE SYSTEM; HEMATOLOGIC DISEASE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL LEAVE; MEDICAL RECORD REVIEW; MENTAL DISEASE; OBSERVATIONAL STUDY; OUTPATIENT CARE; PATIENT CARE; PATIENT SELECTION; PRESENTEEISM; PRODUCTIVITY; SOCIETY; SPAIN; ULCERATIVE COLITIS; COST OF ILLNESS; ECONOMICS; MIDDLE AGED; PUBLIC HEALTH; RETROSPECTIVE STUDY;

ABSENTEEISM; ADULT; COLITIS, ULCERATIVE; COST OF ILLNESS; FEMALE; HEALTH CARE COSTS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; RETROSPECTIVE STUDIES; SPAIN;

EID: 84952985155     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2015.04.007     Document Type: Article

References (33)

1. Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., Brant S.R., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005, 19(Suppl. A):5-36.
2. Mendoza J.L., Lana R., Taxonera C., Alba C., Izquierdo S., Díaz-Rubio M. Manifestaciones extraintestinales en la enfermedad inflamatoria intestinal: diferencias entre la enfermedad de Crohn y la colitis ulcerosa. Med Clin 2005, 125:297-300.
3. Stange E.F., Travis S.P., Vermeire S., Reinisch W., Geboes K., Barakauskiene A., et al. European Crohn's and Colitis Organisation (ECCO): European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Cronhs Colitis 2008, 2:1-23.
4. Bermejo F., Guerra I., López-Sanromán Colitis ulcerosa. Medicine 2012, 11:266-274.
5. Danese S., Fiocchi C. Ulcerative colitis. N Engl J Med 2011, 365:1713-1725.
6. Hart A.R., Luben R., Olsen A., Tjonneland A., Linseisen J., Nagel G., et al. Diet in the aetiology of ulcerative colitis: a European prospective cohort study. Digestion 2008, 77:57-64.
7. López-Serrano P., Pérez-Calle J.L., Carrera-Alonso E., Pérez-Fernández T., Rodríguez-Caravaca G., Boixeda-de-Miguel D., et al. Epidemiologic study on the current incidence of inflammatory bowel disease in Madrid. Rev Esp Enferm Dig 2009, 101:768-772.
8. Cosnes J., Gower-Rousseau C., Seksik P., Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011, 140:1785-1794.
9. Rivera R., de Sola C., Ubiña E., Pérez-Milla E., Fernández F., Navarro J.M., et al. Incidencia y aspectos clinicoepidemiológicos de la colitis ulcerosa en el área de influencia del Hospital Costa del Sol. Gastroenterol Hepatol 2007, 30:7-10.
10. Holtmann M.H., Galle P.R. Current concept of pathophysiological understanding and natural course of ulcerative colitis. Langenbecks Arch Surg 2004, 389:341-349.
11. Bojic D., Radojicic Z., Nedeljkovic-Protic M., Al-Ali M., Jewell D.P., Travis S.P. Long-term outcome after admission for acute severe ulcerative colitis in Oxford: the 1992-1993 cohort. Inflamm Bowel Dis 2009, 15:823-828.
12. Nurmi E., Haapaäki J., Paavilainen E., Rantanen A., Hillilä M., Arkkila P. The burden of inflammatory bowel disease on health care utilization and quality of life. Scand J Gastroenterol 2013, 48:51-57.
13. Holubar S.D., Long K.H., Loftus E.V., Wolff B.G., Pemberton J.H., Cima R.R. Long-term direct costs before and after proctocolectomy for ulcerative colitis: a population-based study in Olmsted County, Minessota. Dis Colon Rectum 2009, 52:1815-1823.
14. Estudio prospectivo DELPHI (costes sociales y económicos de la enfermedad inflamatoria intestinal) 2005, Nexus, Madrid.
15. Bassi A., Dodd S., Williamson P., Bodger K. Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. Gut 2004, 53:1471-1478.
16. Fedorak R.N., Wong K. Bridges. Canadian Digestive Health Foundation Public Impact Series. Inflammatory bowel disease in Canada: incidence, prevalence, and direct and indirect economic impact. Can J Gastroenterol 2010, 24:651-655.
17. World Health Organization International classification of primary care (ICPC-2) 2013, http://www.who.int/classifications/icd/adaptations/icpc2/en/ [accessed June 2014]. second ed.
18. Diari Oficial de la Generalitat de Catalunya 2013, http://portaldogc.gencat.cat/utilsEADOP/PDF/6079/1227866.pdf [accessed June 2014].
19. Boletín Oficial del Estado 2012, http://www.boe.es/boe/dias/2012/12/31/pdfs/BOE-A-2012-15766.pdf.
20. Akaike H. A new look at the statistical model identification. IEE Trans Automat Control 1974, 19:716-723.
21. Burnhan K., Anderson D. Model selection and multimodel inference: a practical information-theoretic approach 2002, Springer-Verlag.
22. A language and environment for statistical computing 2014, R Foundation for Statistical Computing, http://www.R-project.org [accessed June 2014].
23. Cohen R.D., Yu A.P., Wu E.Q., Xie J., Mulani P.M., Chao J. Systematic review: the costs of ulcerative colitis in Western countries. Aliment Pharmacol Ther 2010, 31:693-707.
24. Burisch J., Pedersen N., Čuković-Čavka S., Brinar M., Kaimakliotis I., Duricova D., et al. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut 2014, 63:588-597.
25. van der Valk M.E., Mangen M.J., Leenders M., Dijkstra G., van Bodegraven A.A., Fidder H.H., et al. Healthcare costs of inflammatory bowel disease have shifted from hospitalization and surgery towards anti-TNFα therapy: results from the COIN study. Gut 2014, 63:72-79.
26. Kohn A., Fano V., Monterubbianesi R., Davoli M., Marrollo M., Stasi E., et al. Surgical and nonsurgical hospitalization rates and charges for patients with ulcerative colitis in Italy: a 10-year cohort study. Dig Liver Dis 2012, 44:369-374.
27. Cima R.R., Pemberton J.H. Medical and surgical management of chronic ulcerative colitis. Arch Surg 2005, 140:300-310.
28. Panés J., Guilera M., Ginard D., Hinojosa J., González-Carro P., González-Lara V., et al. Treatment cost of ulcerative colitis is apheresis with Adacolumn cost-effective?. Dig Liver Dis 2007, 39:617-625.
29. Stark R., König H.H., Leidl R. Costs of inflammatory bowel disease in Germany. Pharmacoeconomics 2006, 24:797-814.
30. Blomqvist P., Ekbom A. Inflammatory bowel diseases: health care and costs in Sweden in 1994. Scand J Gastroenterol 1997, 32:1134-1139.
31. Odes S., Vardi H., Friger M., Wolters F., Russel M.G., Riis L., et al. European Collaborative Study on Inflammatory Bowel Disease: cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. Gastroenterology 2006, 131:719-728.
32. Longobardi T., Walker J.R., Graff L.a., Bernstein C.N. Health service utilization in IBD: comparison of self-report and administrative data. BMC Health Serv Res 2011, 11:137.
33. Bickston S., Waters H.C., Dabbous O., Tang B., Rahman M.I. Administrative claims analysis of all-cause annual costs of care and resource utilization by age category for ulcerative colitis patients. J Manag Care Pharm 2008, 14:352-362.